1. Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study. Issue 6 (1st April 2021) Authors: Farag, Mina S.; Fung, Scott; Tam, Edward; Doucette, Karen; Wong, Alexander; Ramji, Alnoor; Conway, Brian; Cooper, Curtis; Tsoi, Keith; Wong, Philip; Sebastiani, Giada; Brahmania, Mayur; Haylock‐Jacobs, Sarah; Coffin, Carla S.; Hansen, Bettina E.; Janssen, Harry L.A. Journal: Journal of viral hepatitis Issue: Volume 28:Issue 6(2021) Page Start: 942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial. Issue 9973 (21st March 2015) Authors: Lawitz, Eric; Gane, Edward; Pearlman, Brian; Tam, Edward; Ghesquiere, Wayne; Guyader, Dominique; Alric, Laurent; Bronowicki, Jean-Pierre; Lester, Laura; Sievert, William; Ghalib, Reem; Balart, Luis; Sund, Fredrik; Lagging, Martin; Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy; Howe, Anita Y M;... Journal: Lancet Issue: Volume 385:Issue 9973(2015) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial. Issue 9973 (21st March 2015) Authors: Lawitz, Eric; Gane, Edward; Pearlman, Brian; Tam, Edward; Ghesquiere, Wayne; Guyader, Dominique; Alric, Laurent; Bronowicki, Jean-Pierre; Lester, Laura; Sievert, William; Ghalib, Reem; Balart, Luis; Sund, Fredrik; Lagging, Martin; Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy; Howe, Anita Y M;... Journal: Lancet Issue: Volume 385:Issue 9973(2015) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results. (June 2019) Authors: Lik Yuen Chan, Henry; Lampertico, Pietro; Buti, Maria; Fung, Scott; Ahn, Sang Hoon; Chuang, Wan-Long; Tak, Won Young; Ramji, Alnoor; Chen, Chi-Yi; Tam, Edward; Bae, Ho; Ma, Xiaoli; Flaherty, John; Gaggar, Anuj; Lau, Audrey; Feierbach, Becket; Wu, George; Suri, Vithika; Subramanian, Mani; Trinh, Huy Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1. Issue 6 (14th March 2019) Authors: Zeuzem, Stefan; Bourgeois, Stefan; Greenbloom, Susan; Buti, Maria; Aghemo, Alessio; Lampertico, Pietro; Janczewska, Ewa; Lim, Seng Gee; Moreno, Christophe; Buggisch, Peter; Tam, Edward; Corbett, Chris; Willems, Wouter; Vijgen, Leen; Fevery, Bart; Ouwerkerk‐Mahadevan, Sivi; Ackaert, Oliver; Beumon... Journal: Hepatology Issue: Volume 69:Issue 6(2019) Page Start: 2349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials. (5th December 2017) Authors: Tam, Edward; Luetkemeyer, Anne F.; Mantry, Parvez S.; Satapathy, Sanjaya K.; Ghali, Peter; Kang, Minhee; Haubrich, Richard; Shen, Xianlin; Ni, Liyun; Camus, Gregory; Copans, Amanda; Rossaro, Lorenzo; Guyer, Bill; Brown, Robert S. Journal: Liver international Issue: Volume 38:Number 6(2018) Page Start: 1010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019) Authors: Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C. (21st February 2022) Authors: Loucks, Catrina M.; Lin, Jennifer J.; Trueman, Jessica N.; Drögemöller, Britt I.; Wright, Galen E. B.; Chang, Wan‐Chun; Li, Kathy H.; Yoshida, Eric M.; Ford, Jo‐Ann; Lee, Samuel S.; Crotty, Pam; Kim, Richard B.; Al‐Judaibi, Bandar; Schwarz, Ute I.; Ramji, Alnoor; Farivar, Jeanette F.; Tam, Edward... Journal: Liver international Issue: Volume 42:Number 4(2022) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015) Authors: Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 7(2015) Page Start: 829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗